A better understanding of the interplay between autophagy and GPCR signaling networks will be very helpful to develop pharmacological strategies based on specific GPCR modulation with potential application to a great number of pathological situations, ranging from vascular and cancer to neurological diseases. Here, GPRC6A is linked to nervous system disorder.